Wright will oversee global commercial, marketing and manufacturing operations at the disposable medical device company.
“I am honored to take on the role of President at this important point in Merit’s journey,” Wright said. “I have been a part of this team for almost two decades and have developed a deep appreciation of Merit’s innovative technology, global access, unique and successful culture, alignment of values within the healthcare system and opportunities for growth. I look forward to advancing our CGI objectives, improving the profitability of our business, and investing in our future.”
Most recently, Wright was chief commercial officer of Merit Medical where he led the development and expansion of the company’s global commercial activities. Before that, he was president of Merit’s international division, leading business units across APAC and the Americas. In that role, he oversaw the development of Merit’s commercial strategy. He led the expansion of the company’s international footprint, including creating Merit China in Beijing and the Merit Asia headquarters in Hong Kong.
“Investing in our people is a core part of the growth and profitability of our Continued Growth Initiatives Program,” Chair and CEO Fred Lampropoulos said in a news release. “Joe has been central to executing our strategic plan and positioning the company for continued success, including spearheading our commercialization efforts and overseeing significant international expansion, engineering the advanced capabilities of our renal therapies group, including the integration of the business and assets we acquired from AngioDynamics in 2023, and directing the development of our commercial excellence initiatives globally. He is a valuable member of our leadership team, and I look forward to continuing to work closely with him to improve the lives of patients and drive sustained value creation for our shareholders.”
Merit Medical’s board of directors is continuing its process of identifying potential internal and external CEO candidates to prepare for CEO Lampropoulos’ retirement at the end of 2025.
